AT502275B8 - Immunantwort-induzierende zusammensetzungen - Google Patents

Immunantwort-induzierende zusammensetzungen Download PDF

Info

Publication number
AT502275B8
AT502275B8 AT0133205A AT13322005A AT502275B8 AT 502275 B8 AT502275 B8 AT 502275B8 AT 0133205 A AT0133205 A AT 0133205A AT 13322005 A AT13322005 A AT 13322005A AT 502275 B8 AT502275 B8 AT 502275B8
Authority
AT
Austria
Prior art keywords
immune response
response inducing
inducing compositions
compositions
immune
Prior art date
Application number
AT0133205A
Other languages
English (en)
Other versions
AT502275B1 (de
AT502275A1 (de
Original Assignee
Greenhills Biotechnology Res D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greenhills Biotechnology Res D filed Critical Greenhills Biotechnology Res D
Priority to AT0133205A priority Critical patent/AT502275B8/de
Priority to EP06760822A priority patent/EP1912670A2/de
Priority to PCT/AT2006/000335 priority patent/WO2007016715A2/en
Priority to CA002615687A priority patent/CA2615687A1/en
Priority to US12/063,388 priority patent/US20090123495A1/en
Priority to AU2006279236A priority patent/AU2006279236A1/en
Publication of AT502275A1 publication Critical patent/AT502275A1/de
Publication of AT502275B1 publication Critical patent/AT502275B1/de
Application granted granted Critical
Publication of AT502275B8 publication Critical patent/AT502275B8/de
Priority to US13/099,810 priority patent/US20110268764A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT0133205A 2005-08-08 2005-08-08 Immunantwort-induzierende zusammensetzungen AT502275B8 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AT0133205A AT502275B8 (de) 2005-08-08 2005-08-08 Immunantwort-induzierende zusammensetzungen
EP06760822A EP1912670A2 (de) 2005-08-08 2006-08-08 Zubereitungen zur auslösung einer immunantwort
PCT/AT2006/000335 WO2007016715A2 (en) 2005-08-08 2006-08-08 Immune response inducing preparations
CA002615687A CA2615687A1 (en) 2005-08-08 2006-08-08 Immune response inducing preparations
US12/063,388 US20090123495A1 (en) 2005-08-08 2006-08-08 Immune Response Inducing Preparations
AU2006279236A AU2006279236A1 (en) 2005-08-08 2006-08-08 Immune response inducing preparations
US13/099,810 US20110268764A1 (en) 2005-08-08 2011-05-03 Immune response inducing preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0133205A AT502275B8 (de) 2005-08-08 2005-08-08 Immunantwort-induzierende zusammensetzungen

Publications (3)

Publication Number Publication Date
AT502275A1 AT502275A1 (de) 2007-02-15
AT502275B1 AT502275B1 (de) 2007-07-15
AT502275B8 true AT502275B8 (de) 2007-08-15

Family

ID=37603079

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0133205A AT502275B8 (de) 2005-08-08 2005-08-08 Immunantwort-induzierende zusammensetzungen

Country Status (6)

Country Link
US (2) US20090123495A1 (de)
EP (1) EP1912670A2 (de)
AT (1) AT502275B8 (de)
AU (1) AU2006279236A1 (de)
CA (1) CA2615687A1 (de)
WO (1) WO2007016715A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL200977B1 (pl) * 1998-06-12 2009-02-27 Sinai School Medicine Atenuowany wirus grypy, genetycznie zmodyfikowany atenuowany wirus grypy, kompozycje szczepionek i kompozycje farmaceutyczne
CN102727880A (zh) 2004-06-01 2012-10-17 西奈山医学院 遗传工程猪流感病毒及其应用
EP1855713B1 (de) * 2005-02-15 2016-04-27 Mount Sinai School of Medicine Gentechnisch hergestellter pferde-influenza-virus und seine verwendungen
HUE031411T2 (en) 2007-03-02 2017-07-28 Glaxosmithkline Biologicals Sa New Methods and Preparations
EP2048237A1 (de) * 2007-10-05 2009-04-15 Avir Green Hills Biotechnology Research Development Trade Ag Replikationsdefizienter Influenza-Virus zur Expression heterologer Sequenzen
US10653766B2 (en) 2014-03-12 2020-05-19 Bavarian Nordic A/S Use of oil and water emulsions for increasing B cell responses with modified Vaccinia Ankara virus
KR20170122786A (ko) 2015-02-26 2017-11-06 베링거잉겔하임베트메디카게엠베하 2가 돼지 인플루엔자 바이러스 백신

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022726A (en) * 1992-02-03 2000-02-08 Palese; Peter Genetically engineered attenuated viruses
US5843724A (en) * 1995-04-27 1998-12-01 Rutgers University Chimeric nucleic acids and proteins for inhibiting HIV-1 expression
JP2002508748A (ja) * 1997-05-01 2002-03-19 カイロン コーポレイション アジュバントとしてのウイルス様粒子の使用
PL200977B1 (pl) * 1998-06-12 2009-02-27 Sinai School Medicine Atenuowany wirus grypy, genetycznie zmodyfikowany atenuowany wirus grypy, kompozycje szczepionek i kompozycje farmaceutyczne
WO1999064571A1 (en) * 1998-06-12 1999-12-16 Mount Sinai School Of Medicine Of The City University Of New York Interferon inducing genetically engineered attenuated viruses
EP1087789A2 (de) * 1998-06-26 2001-04-04 Aventis Pasteur Verwendung von pockenviren als mittel zur erhöhung der spezifischen immunität
AU2001250352B2 (en) * 2000-03-02 2006-01-12 Polymun Scientific Immunbiologische Forschung Gmbh Recombinant influenza a viruses
US6635416B2 (en) * 2000-04-10 2003-10-21 Mount Sinai School Of Medicine Of New York University Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents

Also Published As

Publication number Publication date
AT502275B1 (de) 2007-07-15
WO2007016715A2 (en) 2007-02-15
EP1912670A2 (de) 2008-04-23
AT502275A1 (de) 2007-02-15
AU2006279236A1 (en) 2007-02-15
CA2615687A1 (en) 2007-02-15
US20090123495A1 (en) 2009-05-14
US20110268764A1 (en) 2011-11-03
WO2007016715A3 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
ITMI20041252A1 (it) Composizioni perfluoroelastomeriche
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
DK1968631T3 (da) Vaccine
NO20055686D0 (no) Sammensetning
DE602005016978D1 (de) Quecksilberfreisetzende Zusammensetzungen
ATE469205T1 (de) Reinigungszusammensetzungen
DE602006012066D1 (de) Daraus
DE502006006590D1 (de) Biozide zusammensetzungen
DK1979388T3 (da) Elastiske methacrylatsammensætninger
FR2883132B1 (fr) Composition alimentaire suppletive
DE602005024486D1 (de) Anthrapyridonfarbstoffe
DE102005001875B4 (de) Sessel
AT502275B8 (de) Immunantwort-induzierende zusammensetzungen
DE502006005207D1 (de) Bauteilen
FR2882894B1 (fr) Composition alimentaire suppletive
DE602006009070D1 (de) Lichtstabilisierte copolyetheresterzusammensetzungen
TR200602046A3 (tr) Vitrin
NO20050614L (no) Refractory compositions
DE602005007850D1 (de) Kochgerät
NO20055630D0 (no) SmartCoupling - non responsive
DE602006007934D1 (de) Kochgerät
GB0515658D0 (en) Compositions for inducing an immune response
FI20050783A0 (fi) Ravintokoostumus
UA11010S (uk) Блузка
ES1061164Y (es) Babero

Legal Events

Date Code Title Description
PC Change of the owner

Owner name: BAXTER HEALTHCARE SA, CH

Effective date: 20131008

MM01 Lapse because of not paying annual fees

Effective date: 20150808